Horneff, Gerd http://orcid.org/0000-0001-5491-7832
Minden, Kirsten
Rolland, Catherine
Daly, Ana C. Hernandez
Borlenghi, Cecilia
Ruperto, Nicolino
Funding for this research was provided by:
Pfizer
Article History
Received: 8 September 2022
Accepted: 29 January 2023
First Online: 24 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: GH declares serving on advisory boards and receiving research funds and honoraria from AbbVie, Chugai, GSK, MSD, Pfizer, Roche, and Sobi. KM declares serving on advisory boards and receiving honoraria from AbbVie, GSK, Novartis, Pfizer, Roche, and Sanofi. CR was an employee of Envision Pharma Group at the time the study was conducted and was a paid consultant to Pfizer in connection with the development of the manuscript. ACHD declares former employment with Pfizer, the sponsor of this systematic literature review, and holds stock and/or stock options with Pfizer. CB is an employee of Pfizer and holds stock and/or stock options with Pfizer. NR declares receiving honoraria for consultancies and serving on speakers bureaux for Ablynx, AstraZeneca-Medimmune, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, GSK, Hoffmann-La Roche, Janssen, MSD, Novartis, Pfizer, R-Pharma, Sanofi, Servier, Sinergie, and Sobi; and is a full-time public employee of the IRCCS Istituto Giannina Gaslini that has received contributions from Bristol Myers Squibb, Eli Lilly, GSK, Hoffmann-La Roche, Janssen, Novartis, Pfizer, and Sobi, all of which have been invested in the research activities of the hospital in a fully independent manner and without any commitment to third parties.